Manuel Galvan

1.5k total citations · 1 hit paper
28 papers, 1.2k citations indexed

About

Manuel Galvan is a scholar working on Immunology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Manuel Galvan has authored 28 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 6 papers in Pathology and Forensic Medicine and 5 papers in Molecular Biology. Recurrent topics in Manuel Galvan's work include Complement system in diseases (9 papers), Spinal Cord Injury Research (6 papers) and Neuroinflammation and Neurodegeneration Mechanisms (4 papers). Manuel Galvan is often cited by papers focused on Complement system in diseases (9 papers), Spinal Cord Injury Research (6 papers) and Neuroinflammation and Neurodegeneration Mechanisms (4 papers). Manuel Galvan collaborates with scholars based in United States, Netherlands and Australia. Manuel Galvan's co-authors include Aileen J. Anderson, Hal X. Nguyen, Kevin D. Beck, Trent M. Woodruff, Desirée L. Salazar, Suzanne S. Bohlson, Mallary C. Greenlee‐Wacker, Andrea J. Tenner, Mitra J. Hooshmand and Erliang Zeng and has published in prestigious journals such as Journal of Neuroscience, Blood and The Journal of Immunology.

In The Last Decade

Manuel Galvan

27 papers receiving 1.2k citations

Hit Papers

Quantitative analysis of cellular inflammation after trau... 2010 2026 2015 2020 2010 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Manuel Galvan United States 15 479 384 344 255 246 28 1.2k
Faith H. Brennan United States 19 425 0.9× 364 0.9× 450 1.3× 180 0.7× 253 1.0× 27 1.2k
Hirokazu Saiwai Japan 16 404 0.8× 191 0.5× 156 0.5× 198 0.8× 285 1.2× 47 968
Ian Sutton Australia 20 363 0.8× 542 1.4× 135 0.4× 312 1.2× 352 1.4× 43 2.0k
Mohammad K. Sharief United Kingdom 13 963 2.0× 445 1.2× 190 0.6× 124 0.5× 282 1.1× 18 1.7k
Jennifer L. Berard Canada 9 220 0.5× 321 0.8× 321 0.9× 100 0.4× 238 1.0× 9 929
Alison K. Cross United Kingdom 17 664 1.4× 230 0.6× 196 0.6× 102 0.4× 290 1.2× 30 1.4k
Dongdong Jiang China 15 330 0.7× 118 0.3× 192 0.6× 119 0.5× 846 3.4× 39 1.3k
Douglas Kazutoshi Sato Brazil 28 2.5k 5.3× 362 0.9× 295 0.9× 189 0.7× 371 1.5× 85 3.2k
Christopher Harp United States 18 607 1.3× 900 2.3× 219 0.6× 70 0.3× 380 1.5× 32 1.8k
Shuhei Nishiyama Japan 21 1.3k 2.7× 227 0.6× 241 0.7× 123 0.5× 333 1.4× 65 1.8k

Countries citing papers authored by Manuel Galvan

Since Specialization
Citations

This map shows the geographic impact of Manuel Galvan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuel Galvan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuel Galvan more than expected).

Fields of papers citing papers by Manuel Galvan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manuel Galvan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuel Galvan. The network helps show where Manuel Galvan may publish in the future.

Co-authorship network of co-authors of Manuel Galvan

This figure shows the co-authorship network connecting the top 25 collaborators of Manuel Galvan. A scholar is included among the top collaborators of Manuel Galvan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manuel Galvan. Manuel Galvan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Bai, Xiyuan, Deepshikha Verma, Kevin Kim, et al.. (2023). Ex vivo and in vivo evidence that cigarette smoke-exposed T regulatory cells impair host immunity against Mycobacterium tuberculosis. Frontiers in Cellular and Infection Microbiology. 13. 1216492–1216492. 2 indexed citations
3.
Gómez-Escobar, Luis G., Justin J. Choi, Alain Borczuk, et al.. (2021). Cytokine signatures of end organ injury in COVID-19. Scientific Reports. 11(1). 12606–12606. 31 indexed citations
4.
Hooshmand, Mitra J., et al.. (2020). Complement C6 deficiency exacerbates pathophysiology after spinal cord injury. Scientific Reports. 10(1). 19500–19500. 2 indexed citations
5.
Wiles, Jason A., Manuel Galvan, Steven D. Podos, Michael Geffner, & Mingjun Huang. (2019). Discovery and Development of the Oral Complement Factor D Inhibitor Danicopan (ACH-4471). Current Medicinal Chemistry. 27(25). 4165–4180. 33 indexed citations
6.
Beernink, Peter T., Joanne M. Langley, Soren Gantt, et al.. (2019). Anti-Factor H Antibody Reactivity in Young Adults Vaccinated with a Meningococcal Serogroup B Vaccine Containing Factor H Binding Protein. mSphere. 4(4). 10 indexed citations
7.
Kasotakis, George, Manuel Galvan, Elizabeth G. King, et al.. (2017). Valproic acid mitigates the inflammatory response and prevents acute respiratory distress syndrome in a murine model of Escherichia coli pneumonia at the expense of bacterial clearance. The Journal of Trauma: Injury, Infection, and Critical Care. 82(4). 758–765. 19 indexed citations
8.
Kasotakis, George, et al.. (2017). Timing of valproic acid in acute lung injury: prevention is the best therapy?. Journal of Surgical Research. 220. 206–212. 9 indexed citations
9.
Thanassi, Jane A., Guangwei Yang, Manuel Galvan, et al.. (2016). Comparison of complement functional assays: Differential sensitivities of hemolysis and Wieslab assays to levels of complement proteins C5, factor B, and factor D. Immunobiology. 221(10). 1169–1169. 1 indexed citations
11.
Galvan, Manuel, et al.. (2014). Complement Protein C1q and Adiponectin Stimulate Mer Tyrosine Kinase-Dependent Engulfment of Apoptotic Cells through a Shared Pathway. Journal of Innate Immunity. 6(6). 780–792. 26 indexed citations
12.
13.
Galvan, Manuel, et al.. (2012). Complement component C1q regulates macrophage expression of Mer tyrosine kinase to promote clearance of apoptotic cells (171.31). The Journal of Immunology. 188(1_Supplement). 171.31–171.31. 1 indexed citations
14.
Greenlee‐Wacker, Mallary C., Manuel Galvan, & Suzanne S. Bohlson. (2012). CD93: Recent Advances and Implications in Disease. Current Drug Targets. 13(3). 411–420. 39 indexed citations
15.
Beck, Kevin D., Hal X. Nguyen, Manuel Galvan, et al.. (2010). Quantitative analysis of cellular inflammation after traumatic spinal cord injury: evidence for a multiphasic inflammatory response in the acute to chronic environment. Brain. 133(2). 433–447. 515 indexed citations breakdown →
16.
Vera, A., Agathe León, Rufo Lorente, et al.. (2009). Viral kinetics during the first month of treatment in patients with genotype 1 chronic hepatitis C. Revista Española de Enfermedades Digestivas. 101(10). 671–9. 4 indexed citations
17.
Nguyen, Hal X., Manuel Galvan, & Aileen J. Anderson. (2008). Characterization of early and terminal complement proteins associated with polymorphonuclear leukocytes in vitro and in vivo after spinal cord injury. Journal of Neuroinflammation. 5(1). 26–26. 53 indexed citations
18.
Galvan, Manuel, Sabina Luchetti, Adrian M Burgos, et al.. (2008). Deficiency in Complement C1q Improves Histological and Functional Locomotor Outcome after Spinal Cord Injury. Journal of Neuroscience. 28(51). 13876–13888. 66 indexed citations
19.
Li, M., Karntipa Pisalyaput, Manuel Galvan, & Andrea J. Tenner. (2004). Macrophage colony stimulatory factor and interferon‐γ trigger distinct mechanisms for augmentation of β‐amyloid‐induced microglia‐mediated neurotoxicity. Journal of Neurochemistry. 91(3). 623–633. 37 indexed citations
20.
Galvan, Manuel, et al.. (2003). Human Cord Blood Leukocyte Innate Immune Responses to Defense Collagens. Pediatric Research. 54(5). 724–731. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026